# reload+after+2024-01-20 07:46:33.124263
address1§10880 Wilshire Boulevard
address2§Suite 2150
city§Los Angeles
state§CA
zip§90024
country§United States
phone§424 248 6500
fax§424 248 6501
website§https://www.pumabiotechnology.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 (neratinib, oral), for the patients with early stage HER2-overexpressed/amplified breast cancer; for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; and for HER2 mutation-positive solid tumors. Its products also includes PB272 (neratinib, intravenous), and PB357. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.
fullTimeEmployees§192
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Alan H. Auerbach', 'age': 53, 'title': 'Founder, Chairman, President, CEO & Secretary', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 1744564, 'exercisedValue': 0, 'unexercisedValue': 114559}, {'maxAge': 1, 'name': 'Mr. Maximo F. Nougues', 'age': 54, 'title': 'CFO & Principal Accounting Officer', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 781470, 'exercisedValue': 0, 'unexercisedValue': 42191}, {'maxAge': 1, 'name': 'Dr. Alvin F. Wong Pharm.d.', 'age': 70, 'title': 'Chief Scientific Officer', 'yearBorn': 1953, 'fiscalYear': 2022, 'totalPay': 809691, 'exercisedValue': 0, 'unexercisedValue': 30455}, {'maxAge': 1, 'name': 'Mr. Douglas  Hunt B.Sc., FRAPS', 'age': 58, 'title': 'Senior Vice President of Regulatory Affairs, Pharmacovigilance, Medical Affairs & Law', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 632647, 'exercisedValue': 0, 'unexercisedValue': 15367}, {'maxAge': 1, 'name': 'Mr. Jeffrey Jerome Ludwig', 'age': 57, 'title': 'Chief Commercial Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 916852, 'exercisedValue': 0, 'unexercisedValue': 26543}, {'maxAge': 1, 'name': 'Mr. Mariann  Ohanesian', 'title': 'Senior Director of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§3
boardRisk§5
compensationRisk§8
shareHolderRightsRisk§3
overallRisk§5
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.349
priceToSalesTrailing12Months§0.9737071
currency§USD
dateShortInterest§1702598400
forwardEps§0.3
pegRatio§0.04
exchange§NMS
quoteType§EQUITY
shortName§Puma Biotechnology Inc
longName§Puma Biotechnology, Inc.
firstTradeDateEpochUtc§1335274200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§d6826fe4-7046-3d7e-a75d-eeead91bb387
gmtOffSetMilliseconds§-18000000
targetHighPrice§8.0
targetLowPrice§2.0
targetMeanPrice§4.67
targetMedianPrice§4.0
recommendationMean§3.0
recommendationKey§hold
numberOfAnalystOpinions§3
quickRatio§1.692
grossMargins§0.75911003
ebitdaMargins§0.16593
trailingPegRatio§None
